Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.15 USD | -1.42% |
|
-7.71% | -27.35% |
Jun. 26 | Intellia Therapeutics Names Edward Dulac CFO | MT |
Jun. 26 | Intellia Therapeutics, Inc. Announces Executive Changes | CI |
Financials (USD)
Sales 2024 * | 68.47M | Sales 2025 * | 59.76M | Capitalization | 2.14B |
---|---|---|---|---|---|
Net income 2024 * | -489M | Net income 2025 * | -530M | EV / Sales 2024 * | 22.6 x |
Net cash position 2024 * | 587M | Net cash position 2025 * | 401M | EV / Sales 2025 * | 29 x |
P/E ratio 2024 * |
-4.31
x | P/E ratio 2025 * |
-4.16
x | Employees | 526 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.74% |
Latest transcript on Intellia Therapeutics, Inc.
1 day | -1.42% | ||
1 week | -11.40% | ||
Current month | -1.03% | ||
1 month | +3.60% | ||
3 months | -18.63% | ||
6 months | -27.35% | ||
Current year | -27.35% |
![Extreme 21.6](/images/extremecours_fleche.png)
![Extreme 21.6](/images/extremecours_fleche.png)
![Extreme 19.37](/images/extremecours_fleche.png)
![Extreme 19.37](/images/extremecours_fleche.png)
![Extreme 19.37](/images/extremecours_fleche.png)
![Extreme 9.18](/images/extremecours_fleche.png)
![Extreme 9.18](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Eliana Clark
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Chief Tech/Sci/R&D Officer | 63 | 19-05-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Cohen
BRD | Director/Board Member | 67 | 19-01-23 |
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Frank Verwiel
CHM | Chairman | 61 | 17-07-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.15% | 2 M€ | -25.75% | ||
4.87% | 1 M€ | 0.00% | - | |
4.17% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 22.15 | -1.42% | 1,433,259 |
24-07-01 | 22.47 | +0.40% | 1,291,352 |
24-06-28 | 22.38 | -3.49% | 5,391,362 |
24-06-27 | 23.19 | +1.22% | 1,526,664 |
24-06-26 | 22.91 | -4.54% | 2,458,140 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.35% | 2.17B | |
+17.72% | 44.44B | |
-10.33% | 37.99B | |
+37.55% | 37.75B | |
+29.36% | 30.78B | |
-8.44% | 27.38B | |
+12.45% | 26.17B | |
+44.19% | 14.15B | |
+31.93% | 12.59B | |
-7.67% | 11.28B |
- Stock Market
- Equities
- NTLA Stock